When he ran for president in 2008, Mayor Giuliani made the claim that he was lucky to be treated for his prostate cancer as a citizen of the United States because the survival rate was 82 percent, compared to 44 percent in Britain. While these statistics are technically accurate, a closer look at them will […]
Sonablate (now Sonacare) Reports Excellent Sales in 2013
Sales of the Sonablate HIFU device for non-invasive treatment for localized prostate cancer were higher than expected in 2013. SonaCare Medical, the developer of the device, reported a sales total of six Sonablate HIFU devices that year, which matches the prior year’s sales record as interest in precision guided treatment technologies for prostate cancer continued […]
HIFU Comes to the UK for Prostate Cancer Treatment
For prostate cancer patients in the United Kingdom, 2014 brought excellent news. For the first time on March 3, 2014, High Intensity Focused Ultrasound (HIFU) became a treatment option for patients at Southampton General Hospital. Until this change, the treatment had only been available to private patients who were able to pay for it out […]
BPA Exposure in Utero Increases Prostate Cancer Risk
BPA has been in the news as a carcinogen many times in the past several years, yet a recent study published in Endocrinology shows yet another potential problem associated with BPA exposure, and this time it is for fetal exposure. According to the University of Illinois at Chicago study, fetal exposure to this common plasticizer can increase […]
New Genetic Biomarker for Prostate Cancer Metastasis
Research Study Verifies New Genetic Biomarker for Prostate Cancer Metastasis Because many types of prostate cancer do not function like cancer, and treatment for these “cancers” is more damaging than the disease itself, finding biomarkers that may indicate a patient’s risk of cancer metastasis is crucial in finding the best treatment protocol for prostate cancer […]
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 21
- Next Page »